G42
Hayat-Vax is a joint collaboration between Sinopharm CNBG and Abu Dhabi’s G42. Meanwhile, the country’s COVID-19 contact tracing app will now also function as a national vaccine registry.
Group 42 and Oxford Nanopore Technologies have released details of a promising end-to-end solution that can mass screen for SARS-CoV-2.